Diabetes Insipidus for USMLE Step 2

Diabetes Insipidus (DI) for the USMLE Step 2 Exam
  • Pathophysiology
    • Impaired ADH Activity: Diabetes insipidus (DI) results from inadequate antidiuretic hormone (ADH) secretion or renal insensitivity to ADH, leading to impaired water reabsorption in the kidneys.
    • Excessive Urine Output: Without the action of ADH, the renal collecting ducts cannot concentrate urine, leading to the excretion of large volumes of dilute urine.
    • Polyuria and Polydipsia: Water loss causes significant polyuria, with compensatory polydipsia to maintain fluid balance.
  • Types of DI
    • Central DI: Caused by insufficient ADH secretion from the posterior pituitary.
    • Causes:
    • Idiopathic: Most common cause, likely autoimmune-mediated.
    • Trauma or Surgery: Damage to the hypothalamus or pituitary from head injury or surgery (e.g., transsphenoidal pituitary surgery).
    • Tumors: Craniopharyngiomas, pituitary adenomas, or metastatic lesions.
    • Infiltrative Diseases: Sarcoidosis, Langerhans cell histiocytosis, or tuberculosis affecting the hypothalamus or pituitary.
    • Nephrogenic DI: Caused by renal resistance to ADH.
    • Causes:
    • Genetic: Mutations in the V2 receptor or aquaporin-2 water channels.
    • Medications: Lithium is the most common drug-related cause.
    • Electrolyte Disorders: Hypercalcemia and hypokalemia impair the kidney’s ability to respond to ADH.
    • Chronic Kidney Disease (CKD): Long-standing kidney disease can impair the concentrating ability of the renal tubules.
  • Clinical Features
    • Polyuria: Urine output often exceeds 3 liters/day, and in severe cases, it may reach 15-20 liters/day.
    • Polydipsia: Intense thirst and excessive water intake to compensate for the water lost in urine.
    • Nocturia: Frequent urination at night, which can disturb sleep.
    • Dehydration: Signs include dry mucous membranes, hypotension, and tachycardia if water intake is insufficient.
    • Hypernatremia: If fluid intake does not keep up with losses, serum sodium levels may increase, leading to hypernatremia.
  • Diagnosis
    • Water Deprivation Test:
    • Used to differentiate between central DI, nephrogenic DI, and primary polydipsia.
    • After water deprivation, urine osmolality is measured. Desmopressin is then administered.
    • Central DI: Urine osmolality remains low after deprivation but increases significantly after desmopressin.
    • Nephrogenic DI: Urine osmolality remains low after both water deprivation and desmopressin.
    • Primary Polydipsia: Urine osmolality rises after water deprivation due to normal ADH function.
    • Serum and Urine Osmolality:
    • Serum Osmolality: Elevated (>295 mOsm/kg) due to free water loss.
    • Urine Osmolality: Low (<300 mOsm/kg), indicating dilute urine despite dehydration.
    • Serum Sodium: Hypernatremia (Na+ >145 mEq/L) can develop if the patient cannot compensate for water loss.
  • Treatment
    • Central DI:
    • Desmopressin (DDAVP): Synthetic ADH analog that is the first-line treatment. It can be administered intranasally, orally, or parenterally.
    • Monitoring: Careful monitoring of fluid balance and serum sodium to prevent water intoxication (hyponatremia).
    • Nephrogenic DI:
    • Discontinue Causative Medications: Stopping drugs like lithium may reverse nephrogenic DI.
    • Thiazide Diuretics: Reduce urine output by promoting proximal tubular water reabsorption.
    • Low-Sodium Diet: Reduces the osmotic load on the kidneys and decreases urine output.
    • Amiloride: Especially beneficial in lithium-induced DI by inhibiting lithium entry into renal cells.
  • Complications
    • Hypernatremia: If water intake is insufficient, severe hypernatremia can develop, causing confusion, seizures, or coma.
    • Dehydration: Can lead to hypotension, tachycardia, and shock if not treated adequately.
Key Points
  • Pathophysiology: DI occurs due to insufficient ADH (central DI) or renal resistance to ADH (nephrogenic DI), leading to polyuria and dilute urine.
  • Etiology: Central DI is often idiopathic or secondary to trauma or tumors, while nephrogenic DI may result from lithium use, genetic mutations, or electrolyte imbalances.
  • Diagnosis: The water deprivation test helps distinguish central DI from nephrogenic DI and primary polydipsia. Key findings include elevated serum osmolality and low urine osmolality.
  • Treatment: Central DI is treated with desmopressin, while nephrogenic DI may require thiazide diuretics, a low-sodium diet, and discontinuation of causative drugs.
  • Complications: Hypernatremia and dehydration are serious risks if DI is not managed properly.